In vitro studies have demonstrated that IFN-α increases tumor PD-L1 expression, while PD-1 blockade enhances IFN-α production, resulting in synergistic anti-tumor effects in a B16 melanoma mouse model (50). This evidence concerns the gene CD274 and melanoma.